Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02)

Authors

Institutions

Publication Details

Journal
The Breast
Published
2026-03-13
DOI
https://doi.org/10.1016/j.breast.2026.104749
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02)

Mark Opdam, Annelot G.J. van Rossum, Sara Balduzzi, Hendrika M. Oosterkamp et al.
The Breast
Breast Cancer Treatment Studies
article

Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02)

Mark Opdam, Annelot G.J. van Rossum, Sara Balduzzi, Hendrika M. Oosterkamp, Ingrid A.M. Mandjes, Renee Xavier de Menezes, Jelle Wesseling, Nigel Ultee, Jill J.J. Geenen, Sabine C. Linn, Ingrid Hofland
article en

Abstract

No abstract available for this paper.
The BreastVol. 87
Dutch Cancer Society (NL), The Netherlands Cancer Institute (NL), Medisch Centrum Haaglanden (NL), Oncode Institute (NL)
Amgen, Sanofi
Good health and well-being
Openalex Percentile: Top 23%
Breast Cancer Treatment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.